The global benazepril market is expected to grow at a CAGR of nearly 3.2% during the forecast period (2022-2028). The major factor that drives the global benazepril market is a rise in awareness related to complications associated with hypertension which fuels the growth of the market. Moreover, the increase in the geriatric population and sedentary lifestyle act as key drivers of the global market. However, patent expirations of benazepril hinder the growth of the antihypertensive market. Furthermore, the expansion of high-quality hypertension therapy offered by different associations is expected to fuel the global benazepril market. For instance, in November 2019, The Indian Council of Medical Research (ICMR) has decided to expand its India Hypertension Control Initiative (IHCI) across the country in conjunction with the World Health Organization and the Ministry of Health and Family Welfare.
Browse the full report description “Global Benazepril Market Size, Share & Trends Analysis Report by Type (Purity: 98%, and Purity: 99%) by Dosage Form (Tablet, Capsule, Others) Forecast 2022-2028” at https://www.omrglobal.com/industry-reports/benazepril-market
Market Coverage
Segment Covered-
Regions Covered-
competitive landscape- Novartis International AG, Teva Pharmaceutical Industries Ltd., and Apotex, Inc., among others.
Key questions addressed by the report
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
Global Benazepril Market Report Segment
By Type
By Dosage Form
Global Benazepril Market Report by Region
North America
Europe
Asia-Pacific
Rest of the World
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/benazepril-market